PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
C Jiang, AT Ting, B Seed - Nature, 1998 - nature.com
The peroxisome proliferator-activated receptor-γ (PPAR-γ) is a member of the nuclear receptor
family of transcription factors, a large and diverse group of proteins that mediate ligand-…
family of transcription factors, a large and diverse group of proteins that mediate ligand-…
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei province,
and rapidly spread to many provinces in China as well as other countries. Here we report …
and rapidly spread to many provinces in China as well as other countries. Here we report …
[HTML][HTML] Angiotensin-converting enzyme 2 protects from severe acute lung failure
Acute respiratory distress syndrome (ARDS), the most severe form of acute lung injury, is a
devastating clinical syndrome with a high mortality rate (30–60%) (refs 1 ). Predisposing …
devastating clinical syndrome with a high mortality rate (30–60%) (refs 1 ). Predisposing …
[HTML][HTML] A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
…, T Wada, AS Slutsky, D Liu, C Qin, C Jiang… - Nature medicine, 2005 - nature.com
During several months of 2003, a newly identified illness termed severe acute respiratory
syndrome (SARS) spread rapidly through the world 1, 2, 3. A new coronavirus (SARS-CoV) …
syndrome (SARS) spread rapidly through the world 1, 2, 3. A new coronavirus (SARS-CoV) …
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
Background The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and …
acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and …
[HTML][HTML] Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
…, H Lu, N Li, D Li, N Jin, JM Penninger, C Jiang - Nature …, 2014 - nature.com
The potential for avian influenza H5N1 outbreaks has increased in recent years. Thus, it is
paramount to develop novel strategies to alleviate death rates. Here we show that avian …
paramount to develop novel strategies to alleviate death rates. Here we show that avian …
Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients
…, J Wei, T Xie, H Gao, KF Xu, F Wang, L Liu, C Jiang - MedRxiv, 2020 - medrxiv.org
Background The novel coronavirus (CoV) severe acute respiratory syndrome (SARS)-CoV-2
outbreak started at the end of 2019 in Wuhan, China, and spread over 100 countries. SARS-…
outbreak started at the end of 2019 in Wuhan, China, and spread over 100 countries. SARS-…
[HTML][HTML] The basis of a more contagious 501Y. V1 variant of SARS-CoV-2
…, Z Chen, K Aviszus, J Yang, W Downing, C Jiang… - Cell research, 2021 - nature.com
Dear Editor, The SARS-CoV-2 virus has infected over one hundred million people (COVID-19
patients) and caused more than two million deaths to date. The number of infected people …
patients) and caused more than two million deaths to date. The number of infected people …
[HTML][HTML] Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury
…, S Akira, M Hultqvist, R Holmdahl, J Nicholls, C Jiang… - Cell, 2008 - cell.com
Multiple lung pathogens such as chemical agents, H5N1 avian flu, or SARS cause high
lethality due to acute respiratory distress syndrome. Here we report that Toll-like receptor 4 (TLR4…
lethality due to acute respiratory distress syndrome. Here we report that Toll-like receptor 4 (TLR4…
[PDF][PDF] Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury
A recent outbreak of pneumonia in Wuhan, China was found to be caused by a 2019 novel
coronavirus (2019-nCoV or SARS-CoV-2 or HCoV-19). We previously reported the clinical …
coronavirus (2019-nCoV or SARS-CoV-2 or HCoV-19). We previously reported the clinical …